Pancreatic polypeptide in cystic fibrosis

Area of Science:

• Endocrinology
• Gastroenterology
• Pediatrics

Background:

• Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, including the pancreas.
• Pancreatic function, particularly exocrine and endocrine secretion, can be compromised in CF patients.
• Pancreatic polypeptide (PP) is a hormone secreted by pancreatic islet cells, involved in regulating gastrointestinal functions.

Purpose of the Study:

• To investigate protein meal-stimulated pancreatic polypeptide (PP) secretion in patients with cystic fibrosis (CF) and their relatives.
• To correlate PP secretion patterns with pancreatic function and histological findings in CF.
• To explore the potential of PP secretion as an indicator of pancreatic damage in CF.

Main Methods:

• Studied PP secretion in CF patients, siblings, and parents following a protein meal.
• Assessed plasma insulin levels during the meal tolerance test.
• Performed immunocytochemical and morphometric analyses of pancreatic tissue from autopsied CF patients.

Main Results:

• CF patients with exocrine pancreatic insufficiency showed no PP response to a protein meal.
• CF patients with normal pancreatic function had preserved basal and elevated postmeal PP levels.
• Histological studies revealed reduced islet tissue and PP cells in older CF patients (>9 years).

Conclusions:

• Absent PP secretory response in CF with exocrine insufficiency may indicate defects in the PP secretion mechanism.
• Abnormal PP secretion patterns could serve as an indirect index of pancreatic damage in cystic fibrosis.
• PP secretion warrants further investigation as a potential biomarker in CF management.